Dissecting the mechanisms behind chronic inflammation

Dissecting the mechanisms behind chronic inflammation
Credit: Thinkstock

European scientists joined forces to unravel how a physiological process such as inflammation can turn pathological. Project findings have the potential to provide answers to many inflammatory disorders.

Upon infection or injury, are attracted to the site through the , a process known as inflammation. Although this is considered normal, prolonged activation of this process leads to the pathological state of chronic inflammation. It is becoming increasingly evident that chronic inflammation is the leading cause of many diseases including .

To achieve a thorough understanding of directed inflammatory cell migration towards and across injured tissues, the EU-funded ‘Targeting cell migration in chronmic inflammation’ (MAIN) project brought together over 48 leading research teams in the field.

The MAIN project was divided into tightly interconnected research programmes of highly integrated activities. Some groups were involved in the Tool Development Programme (TDP) which dealt with the development of technological tools including imaging and RNAi interference for studying cell migration. Identification of signalling pathways and molecular networks that regulate inflammatory cell migration was part of the Target Identification Program (TIP) and provided cues to underlying mechanisms of chronic inflammation.

At the same time, potential targets were tested in the Target Validation Program (TVP) using in vitro and in vivo models while novel assays were generated under the project’s Drug Development Program (DDP).

Collectively, the information generated during the MAIN project provided significant basic knowledge on what determines inflammatory and how this goes wrong during chronic inflammation. This information could be exploited for the future design of drugs against .

add to favorites email to friend print save as pdf

Related Stories

Gatekeeper signal controls skin inflammation

Jan 26, 2012

A new study unravels key signals that regulate protective and sometimes pathological inflammation of the skin. The research, published online on January 26th in the journal Immunity by Cell Press, identifies a "gatekeeper" that, ...

First step to new therapy for chronic bowel disease

Jul 06, 2010

Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University (UGent) have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. ...

Recommended for you

Ontario has one of the highest rates of IBD in the world

Aug 28, 2014

One in every 200 Ontarians has been diagnosed with inflammatory bowel disease (IBD), with the number of people living with the disease increasing by 64 per cent between 1999 and 2008, according to a study by researchers at ...

New drug promises relief for inflammatory pain

Aug 27, 2014

Pain from inflammation sidelines thousands of Americans each year. Many face a tough choice: deal with the pain, take a potentially addictive opioid or use a nonsteroidal anti-inflammatory drug that may increase risk for ...

Overweight causes hazardous inflammations

Aug 25, 2014

Researchers have found a possible molecular explanation for why overweight is harmful. This new knowledge may provide new drugs for heart attack, stroke, cancer and chronic intestinal inflammation.

Asthma outcomes worse in older women

Aug 21, 2014

(HealthDay)—Older women face increased challenges in managing their asthma, according to a review published in the August issue of the Annals of Allergy, Asthma & Immunology.

User comments